-
1
-
-
72749120841
-
Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors
-
Allington TM, Galliher-Beckley AJ, Schiemann WP. (2009). Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors. FASEB J 23: 4231-4243.
-
(2009)
FASEB J
, vol.23
, pp. 4231-4243
-
-
Allington, T.M.1
Galliher-Beckley, A.J.2
Schiemann, W.P.3
-
2
-
-
78650517027
-
The cain and Abl of epithelial-mesenchymal transition and transforming growth factor-beta in mammary epithelial cells
-
Allington TM, Schiemann WP. (2011). The cain and Abl of epithelial-mesenchymal transition and transforming growth factor-beta in mammary epithelial cells. Cells Tissues Organs 193: 98-113.
-
(2011)
Cells Tissues Organs
, vol.193
, pp. 98-113
-
-
Allington, T.M.1
Schiemann, W.P.2
-
3
-
-
20144378487
-
Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines
-
DOI 10.1016/j.yexcr.2004.12.019
-
Bachmeier BE, Albini A, Vene R, Benelli R, Noonan D, Weigert C et al. (2005). Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. Exp Cell Res 305: 83-98. (Pubitemid 40380656)
-
(2005)
Experimental Cell Research
, vol.305
, Issue.1
, pp. 83-98
-
-
Bachmeier, B.E.1
Albini, A.2
Vene, R.3
Benelli, R.4
Noonan, D.5
Weigert, C.6
Weiler, C.7
Lichtinghagen, R.8
Jochum, M.9
Nerlich, A.G.10
-
4
-
-
60949103692
-
Melanoma epidemiology and public health
-
Berwick M, Erdei E, Hay J. (2009). Melanoma epidemiology and public health. Dermatol Clin 27: 205-214, viii.
-
(2009)
Dermatol Clin
, vol.27
-
-
Berwick, M.1
Erdei, E.2
Hay, J.3
-
5
-
-
71349087406
-
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
-
Blackburn JS, Liu I, Coon CI, Brinckerhoff CE. (2009). A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 28: 4237-4248.
-
(2009)
Oncogene
, vol.28
, pp. 4237-4248
-
-
Blackburn, J.S.1
Liu, I.2
Coon, C.I.3
Brinckerhoff, C.E.4
-
6
-
-
33847284434
-
A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation
-
Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ. (2007). A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 17: 445-451.
-
(2007)
Curr Biol
, vol.17
, pp. 445-451
-
-
Boyle, S.N.1
Michaud, G.A.2
Schweitzer, B.3
Predki, P.F.4
Koleske, A.J.5
-
7
-
-
0034488852
-
Interstitial collagenases as markers of tumor progression
-
Brinckerhoff CE, Rutter JL, Benbow U. (2000). Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6: 4823-4830. (Pubitemid 32110426)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.12
, pp. 4823-4830
-
-
Brinckerhoff, C.E.1
Rutter, J.L.2
Benbow, U.3
-
8
-
-
18444402504
-
A clinical and biological overview of gastrointestinal stromal tumors
-
Candelaria M, de la Garza J, Duenas-Gonzalez A. (2005). A clinical and biological overview of gastrointestinal stromal tumors. Med Oncol 22: 1-10. (Pubitemid 40647223)
-
(2005)
Medical Oncology
, vol.22
, Issue.1
, pp. 1-10
-
-
Candelaria, M.1
De La, G.J.2
Duenas-Gonzalez, A.3
-
9
-
-
0021743724
-
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
-
Clark Jr WH, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van Horn M. (1984). A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15: 1147-1165. (Pubitemid 15128121)
-
(1984)
Human Pathology
, vol.15
, Issue.12
, pp. 1147-1165
-
-
Clark Jr., W.H.1
Elder, D.E.2
Guerry, D.3
-
11
-
-
62149150709
-
Nanoneoadjuvant therapy of gastrointestinal stromal tumor (GIST)
-
DeMatteo RP. (2009). Nanoneoadjuvant therapy of gastrointestinal stromal tumor (GIST). Ann Surg Oncol 16: 799-800.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 799-800
-
-
DeMatteo, R.P.1
-
12
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
DOI 10.1056/NEJM200104053441401
-
Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031-1037. (Pubitemid 32267972)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.14
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
Peng, B.4
Buchdunger, E.5
Ford, J.M.6
Lydon, N.B.7
Kantarjian, H.8
Capdeville, R.9
Ohno-Jones, S.10
Sawyers, C.L.11
-
13
-
-
77149137406
-
Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
-
Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. (2010). Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 1803: 3-19.
-
(2010)
Biochim Biophys Acta
, vol.1803
, pp. 3-19
-
-
Fanjul-Fernandez, M.1
Folgueras, A.R.2
Cabrera, S.3
Lopez-Otin, C.4
-
14
-
-
77956030786
-
Inhibition of mutated, activated BRAF in metastatic melanoma
-
Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA et al. (2010). Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363: 809-819.
-
(2010)
N Engl J Med
, vol.363
, pp. 809-819
-
-
Flaherty, K.T.1
Puzanov, I.2
Kim, K.B.3
Ribas, A.4
McArthur, G.A.5
Sosman, J.A.6
-
15
-
-
80052693990
-
Abl interconnects oncogenic Met and p53 core pathways in cancer cells
-
e-pub ahead of print
-
Furlan A, Stagni V, Hussain A, Richelme S, Conti F, Prodosmo A et al. (2011). Abl interconnects oncogenic Met and p53 core pathways in cancer cells. Cell Death Differ (e-pub ahead of print).
-
(2011)
Cell Death Differ
-
-
Furlan, A.1
Stagni, V.2
Hussain, A.3
Richelme, S.4
Conti, F.5
Prodosmo, A.6
-
16
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363: 711-723.
-
(2010)
N Engl J Med
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
-
17
-
-
58849127864
-
Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate
-
Hofmann UB, Kauczok-Vetter CS, Houben R, Becker JC. (2009). Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate. Clin Cancer Res 15: 324-329.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 324-329
-
-
Hofmann, U.B.1
Kauczok-Vetter, C.S.2
Houben, R.3
Becker, J.C.4
-
18
-
-
33644526633
-
Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells
-
Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K et al. (2006). Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 25: 1195-1204.
-
(2006)
Oncogene
, vol.25
, pp. 1195-1204
-
-
Itoh, M.1
Murata, T.2
Suzuki, T.3
Shindoh, M.4
Nakajima, K.5
Imai, K.6
-
19
-
-
28844432679
-
Revealing the genomic heterogeneity of melanoma
-
DOI 10.1016/j.ccr.2005.11.008, PII S1535610805003648
-
Kabbarah O, Chin L. (2005). Revealing the genomic heterogeneity of melanoma. Cancer Cell 8: 439-441. (Pubitemid 41773447)
-
(2005)
Cancer Cell
, vol.8
, Issue.6
, pp. 439-441
-
-
Kabbarah, O.1
Chin, L.2
-
20
-
-
78650493551
-
Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells
-
Kong Y, Kumar SM, Xu X. (2010). Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med 134: 1740-1749.
-
(2010)
Arch Pathol Lab Med
, vol.134
, pp. 1740-1749
-
-
Kong, Y.1
Kumar, S.M.2
Xu, X.3
-
21
-
-
21544473172
-
Targeting STAT3 affects melanoma on multiple fronts
-
DOI 10.1007/s10555-005-1580-1
-
Kortylewski M, Jove R, Yu H. (2005). Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 24: 315-327. (Pubitemid 40922802)
-
(2005)
Cancer and Metastasis Reviews
, vol.24
, Issue.2
, pp. 315-327
-
-
Kortylewski, M.1
Jove, R.2
Yu, H.3
-
22
-
-
12144290456
-
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588
-
DOI 10.1007/s00280-003-0741-6
-
le Coutre P, Kreuzer KA, Pursche S, Bonin M, Leopold T, Baskaynak G et al. (2004). Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588. Cancer Chemother Pharmacol 53: 313-323. (Pubitemid 38392356)
-
(2004)
Cancer Chemotherapy and Pharmacology
, vol.53
, Issue.4
, pp. 313-323
-
-
Le, C.P.1
Kreuzer, K.-A.2
Pursche, S.3
Bonin, M.V.4
Leopold, T.5
Baskaynak, G.6
Dorken, B.7
Ehninger, G.8
Ottmann, O.9
Jenke, A.10
Bornhauser, M.11
Schleyer, E.12
-
23
-
-
77954660827
-
c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein galectin-3
-
Li X, Ma Q, Wang J, Liu X, Yang Y, Zhao H et al. (2010). c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein galectin-3. Cell Death Differ 17: 1277-1287.
-
(2010)
Cell Death Differ
, vol.17
, pp. 1277-1287
-
-
Li, X.1
Ma, Q.2
Wang, J.3
Liu, X.4
Yang, Y.5
Zhao, H.6
-
24
-
-
47949106116
-
Activated c-Abl tyrosine kinase in malignant solid tumors
-
Lin J, Arlinghaus R. (2008). Activated c-Abl tyrosine kinase in malignant solid tumors. Oncogene 27: 4385-4391.
-
(2008)
Oncogene
, vol.27
, pp. 4385-4391
-
-
Lin, J.1
Arlinghaus, R.2
-
25
-
-
35548969446
-
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: Inhibition of c-Abl by the tumor suppressor gene product Fus1
-
DOI 10.1038/sj.onc.1210500, PII 1210500
-
Lin J, Sun T, Ji L, Deng W, Roth J, Minna J et al. (2007). Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1. Oncogene 26: 6989-6996. (Pubitemid 350014606)
-
(2007)
Oncogene
, vol.26
, Issue.49
, pp. 6989-6996
-
-
Lin, J.1
Sun, T.2
Ji, L.3
Deng, W.4
Roth, J.5
Minna, J.6
Arlinghaus, R.7
-
26
-
-
79952845386
-
The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit
-
Lin K, Baritaki S, Militello L, Malaponte G, Bevelacqua Y, Bonavida B. (2010). The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit. Genes Cancer 1: 409-420.
-
(2010)
Genes Cancer
, vol.1
, pp. 409-420
-
-
Lin, K.1
Baritaki, S.2
Militello, L.3
Malaponte, G.4
Bevelacqua, Y.5
Bonavida, B.6
-
27
-
-
79952203229
-
An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion
-
Mader CC, Oser M, Magalhaes MA, Bravo-Cordero JJ, Condeelis J, Koleske AJ et al. (2011). An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 71: 1730-1741.
-
(2011)
Cancer Res
, vol.71
, pp. 1730-1741
-
-
Mader, C.C.1
Oser, M.2
Magalhaes, M.A.3
Bravo-Cordero, J.J.4
Condeelis, J.5
Koleske, A.J.6
-
28
-
-
0346728596
-
Determinants of BRAF mutations in primary melanomas
-
Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T et al. (2003). Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95: 1878-1890.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1878-1890
-
-
Maldonado, J.L.1
Fridlyand, J.2
Patel, H.3
Jain, A.N.4
Busam, K.5
Kageshita, T.6
-
29
-
-
33745889602
-
Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines
-
Mayorga ME, Sanchis D, Perez de Santos AM, Velasco A, Dolcet X, Casanova JM et al. (2006). Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines. Melanoma Res 16: 127-135.
-
(2006)
Melanoma Res
, vol.16
, pp. 127-135
-
-
Mayorga, M.E.1
Sanchis, D.2
Perez De Santos, A.M.3
Velasco, A.4
Dolcet, X.5
Casanova, J.M.6
-
30
-
-
77249135465
-
Treatment for metastatic malignant melanoma: Old drugs and new strategies
-
Mouawad R, Sebert M, Michels J, Bloch J, Spano JP, Khayat D. (2009). Treatment for metastatic malignant melanoma: old drugs and new strategies. Crit Rev Oncol Hematol 74: 27-39.
-
(2009)
Crit Rev Oncol Hematol
, vol.74
, pp. 27-39
-
-
Mouawad, R.1
Sebert, M.2
Michels, J.3
Bloch, J.4
Spano, J.P.5
Khayat, D.6
-
31
-
-
0035452411
-
Quantitative cell dispersion analysis: New test to measure tumor cell aggressiveness
-
DOI 10.1002/ijc.1380
-
Nawrocki Raby B, Polette M, Gilles C, Clavel C, Strumane K, Matos M et al. (2001). Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int J Cancer 93: 644-652. (Pubitemid 32695111)
-
(2001)
International Journal of Cancer
, vol.93
, Issue.5
, pp. 644-652
-
-
Raby, B.N.1
Polette, M.2
Gilles, C.3
Clavel, C.4
Strumane, K.5
Matos, M.6
Zahm, J.-M.7
Van Roy, F.8
Bonnet, N.9
Birembaut, P.10
-
32
-
-
33746646032
-
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway
-
DOI 10.1038/ncb1438, PII NCB1438
-
Noren NK, Foos G, Hauser CA, Pasquale EB. (2006). The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8: 815-825. (Pubitemid 44151584)
-
(2006)
Nature Cell Biology
, vol.8
, Issue.8
, pp. 815-825
-
-
Noren, N.K.1
Foos, G.2
Hauser, C.A.3
Pasquale, E.B.4
-
33
-
-
48049100143
-
Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate
-
Ogawa Y, Kawamura T, Furuhashi M, Tsukamoto K, Shimada S. (2008). Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate. J Dermatol Sci 51: 190-199.
-
(2008)
J Dermatol Sci
, vol.51
, pp. 190-199
-
-
Ogawa, Y.1
Kawamura, T.2
Furuhashi, M.3
Tsukamoto, K.4
Shimada, S.5
-
34
-
-
0010639726
-
BCR-ABL protein domain, function, and signaling
-
Carella AM, Daley GQ, Eaves CJ, Goldman JM, Helmann R (eds). Martin Dunitz Ltd.: London
-
Pendergast AM. (2001). BCR-ABL protein domain, function, and signaling. In: Carella AM, Daley GQ, Eaves CJ, Goldman JM, Helmann R (eds). Chronic Myeloid Leukaemia: Biology and Treatment. Martin Dunitz Ltd.: London, pp 19-39.
-
(2001)
Chronic Myeloid Leukaemia: Biology and Treatment
, pp. 19-39
-
-
Pendergast, A.M.1
-
35
-
-
0026010295
-
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor
-
Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F, Witte ON. (1991). Evidence for regulation of the human Abl tyrosine kinase by a cellular inhibitor. Proc Natl Acad Sci U S A 88: 5927-5931. (Pubitemid 21914859)
-
(1991)
Proceedings of the National Academy of Sciences of the United States of America
, vol.88
, Issue.13
, pp. 5927-5931
-
-
Pendergast, A.M.1
Muller, A.J.2
Havlik, M.H.3
Clark, R.4
Mccormick, F.5
Witte, O.N.6
-
36
-
-
0037384252
-
A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-γ1
-
DOI 10.1038/ncb949
-
Plattner R, Irvin BJ, Guo S, Blackburn K, Kazlauskas A, Abraham RT et al. (2003). A new link between the c-Abl tyrosine kinase and phosphoinositide signaling via PLC-γ1. Nat Cell Biol 5: 309-319. (Pubitemid 36432295)
-
(2003)
Nature Cell Biology
, vol.5
, Issue.4
, pp. 309-319
-
-
Plattner, R.1
Irvin, B.J.2
Guo, S.3
Blackburn, K.4
Kazlauskas, A.5
Abraham, R.T.6
York, J.D.7
Pendergast, A.M.8
-
37
-
-
0033568349
-
c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF
-
DOI 10.1101/gad.13.18.2400
-
Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev 13: 2400-2411. (Pubitemid 29453611)
-
(1999)
Genes and Development
, vol.13
, Issue.18
, pp. 2400-2411
-
-
Plattner, R.1
Kadlec, L.2
Demali, K.A.3
Kazlauskas, A.4
Pendergast, A.M.5
-
38
-
-
34250869019
-
MDA-MB-435 cells are derived from M14 Melanoma cells - A loss for breast cancer, but a boon for melanoma research
-
DOI 10.1007/s10549-006-9392-8
-
Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. (2007). MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104: 13-19. (Pubitemid 46976633)
-
(2007)
Breast Cancer Research and Treatment
, vol.104
, Issue.1
, pp. 13-19
-
-
Rae, J.M.1
Creighton, C.J.2
Meck, J.M.3
Haddad, B.R.4
Johnson, M.D.5
-
40
-
-
73849134744
-
Advances in treatment of chronic myelogenous leukemia - New treatment options with tyrosine kinase inhibitors
-
Santos FP, Ravandi F. (2009). Advances in treatment of chronic myelogenous leukemia - new treatment options with tyrosine kinase inhibitors. Leuk Lymphoma 50(Suppl 2): 16-26.
-
(2009)
Leuk Lymphoma
, vol.50
, Issue.SUPPL. 2
, pp. 16-26
-
-
Santos, F.P.1
Ravandi, F.2
-
41
-
-
76649108873
-
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy - Case report and review of the literature
-
Satzger I, Kuttler U, Volker B, Schenck F, Kapp A, Gutzmer R. (2010). Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy - case report and review of the literature. Dermatology 220: 77-81.
-
(2010)
Dermatology
, vol.220
, pp. 77-81
-
-
Satzger, I.1
Kuttler, U.2
Volker, B.3
Schenck, F.4
Kapp, A.5
Gutzmer, R.6
-
42
-
-
77952236279
-
B-RAF inhibitors: An evolving role in the therapy of malignant melanoma
-
Shepherd C, Puzanov I, Sosman JA. (2010). B-RAF inhibitors: an evolving role in the therapy of malignant melanoma. Curr Oncol Rep 12: 146-152.
-
(2010)
Curr Oncol Rep
, vol.12
, pp. 146-152
-
-
Shepherd, C.1
Puzanov, I.2
Sosman, J.A.3
-
43
-
-
11244303506
-
Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors
-
DOI 10.1677/erc.1.00801
-
Singer CF, Hudelist G, Lamm W, Mueller R, Czerwenka K, Kubista E. (2004). Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors. Endocr Relat Cancer 11: 861-869. (Pubitemid 40065558)
-
(2004)
Endocrine-Related Cancer
, vol.11
, Issue.4
, pp. 861-869
-
-
Singer, C.F.1
Hudelist, G.2
Lamm, W.3
Mueller, R.4
Czerwenka, K.5
Kubista, E.6
-
44
-
-
56149111255
-
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells
-
Sirvent A, Benistant C, Roche S. (2008). Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol Cell 100: 617-631.
-
(2008)
Biol Cell
, vol.100
, pp. 617-631
-
-
Sirvent, A.1
Benistant, C.2
Roche, S.3
-
45
-
-
66049145392
-
Genetic subgrouping of melanoma reveals new opportunities for targeted therapy
-
Smalley KS, Nathanson KL, Flaherty KT. (2009). Genetic subgrouping of melanoma reveals new opportunities for targeted therapy. Cancer Res 69: 3241-3244.
-
(2009)
Cancer Res
, vol.69
, pp. 3241-3244
-
-
Smalley, K.S.1
Nathanson, K.L.2
Flaherty, K.T.3
-
46
-
-
78650043640
-
Abl kinases are required for invadopodia formation and chemokine-induced invasion
-
Smith-Pearson PS, Greuber EK, Yogalingam G, Pendergast AM. (2010). Abl kinases are required for invadopodia formation and chemokine-induced invasion. J Biol Chem 285: 40201-40211.
-
(2010)
J Biol Chem
, vol.285
, pp. 40201-40211
-
-
Smith-Pearson, P.S.1
Greuber, E.K.2
Yogalingam, G.3
Pendergast, A.M.4
-
47
-
-
64849105075
-
Reciprocal regulation of Abl and receptor tyrosine kinases
-
Srinivasan D, Kaetzel DM, Plattner R. (2009). Reciprocal regulation of Abl and receptor tyrosine kinases. Cell Signal 21: 1143-1150.
-
(2009)
Cell Signal
, vol.21
, pp. 1143-1150
-
-
Srinivasan, D.1
Kaetzel, D.M.2
Plattner, R.3
-
48
-
-
33745251071
-
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
-
DOI 10.1158/0008-5472.CAN-06-0734
-
Srinivasan D, Plattner R. (2006). Activation of abl tyrosine kinases promotes invasion of aggressive breast cancer cells. Cancer Res 66: 5648-5655. (Pubitemid 43927117)
-
(2006)
Cancer Research
, vol.66
, Issue.11
, pp. 5648-5655
-
-
Srinivasan, D.1
Plattner, R.2
-
49
-
-
39149121810
-
Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival
-
DOI 10.1038/sj.onc.1210714, PII 1210714
-
Srinivasan D, Sims JT, Plattner R. (2008). Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival. Oncogene 27: 1095-1105. (Pubitemid 351253178)
-
(2008)
Oncogene
, vol.27
, Issue.8
, pp. 1095-1105
-
-
Srinivasan, D.1
Sims, J.T.2
Plattner, R.3
-
50
-
-
34247281958
-
Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction
-
DOI 10.1593/neo.06820
-
Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schutz A, Kovacic B et al. (2007). Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9: 279-291. (Pubitemid 46608295)
-
(2007)
Neoplasia
, vol.9
, Issue.4
, pp. 279-291
-
-
Tsareva, S.A.1
Moriggl, R.2
Corvinus, F.M.3
Wiederanders, B.4
Schutz, A.5
Kovacic, B.6
Friedrich, K.7
-
51
-
-
21044460131
-
Lack of clinical efficacy of imatinib in metastatic melanoma
-
DOI 10.1038/sj.bjc.6602529
-
Ugurel S, Hildenbrand R, Zimpfer A, La Rosee P, Paschka P, Sucker A et al. (2005). Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer 92: 1398-1405. (Pubitemid 40705006)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.8
, pp. 1398-1405
-
-
Ugurel, S.1
Hildenbrand, R.2
Zimpfer, A.3
La, R.P.4
Paschka, P.5
Sucker, A.6
Keikavoussi, P.7
Becker, J.C.8
Rittgen, W.9
Hochhaus, A.10
Schadendorf, D.11
-
52
-
-
0032479139
-
The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
-
DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9
-
Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H et al. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 77: 128-137. (Pubitemid 28308562)
-
(1998)
International Journal of Cancer
, vol.77
, Issue.1
, pp. 128-137
-
-
Watabe, T.1
Yoshida, K.2
Shindoh, M.3
Kaya, M.4
Fujikawa, K.5
Sato, H.6
Seiki, M.7
Ishii, S.8
Fujinaga, K.9
-
53
-
-
58149097087
-
Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components
-
Yogalingam G, Pendergast AM. (2008). Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem 283: 35941-35953.
-
(2008)
J Biol Chem
, vol.283
, pp. 35941-35953
-
-
Yogalingam, G.1
Pendergast, A.M.2
|